A murine study found histone deacetylase 3 (HDAC3) inhibitors reverse epigenetic changes caused by CREBBP mutations found in lymphomas and could be developed into a novel therapy.
List view / Grid view
The University of Texas MD Anderson Cancer Center
Filter the results
An antibody has been developed to block a protein secreted by the cells surrounding ovarian and pancreatic cancer tumours.
A cellular pathway may reduce side effects and extend immunotherapy duration in patients with the most common form of liver cancer.
The enzyme protein kinase C delta (PKCδ) found in NSCLC tumors prevents tyrosine kinase inhibitors (TKIs) from forestalling cancer...